GSK plc (GLAXF)
OTCMKTS · Delayed Price · Currency is USD
21.90
-1.40 (-6.01%)
Oct 31, 2025, 4:00 PM EDT
GSK plc Market Cap
GSK plc has a market cap or net worth of $94.01 billion as of October 31, 2025. Its market cap has increased by 21.19% in one year.
Market Cap
94.01B
Enterprise Value
112.46B
Revenue
43.24B
Ranking
n/a
PE Ratio
12.73
Stock Price
$21.90
Market Cap Chart
Since December 27, 2000, GSK plc's market cap has decreased from 96.45B to 94.01B, a decrease of -2.54%. That is a compound annual growth rate of -0.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 94.01B | 36.66% |
| Dec 31, 2024 | 68.79B | -8.64% |
| Dec 29, 2023 | 75.29B | 7.04% |
| Dec 30, 2022 | 70.34B | -35.43% |
| Dec 31, 2021 | 108.95B | 19.45% |
| Dec 31, 2020 | 91.20B | -21.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 648.67M |
| Glass House Brands | 563.30M |
| Northwest Biotherapeutics | 366.55M |
| Silence Therapeutics | 341.50M |
| Nika Pharmaceuticals | 312.10M |
| CytoDyn | 303.60M |
| American Oncology Network | 297.14M |